#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Michael Yellin Email
VP, Clinical Science . Celldex Therapeutics
Hampton, NJ
Locationm******@celldextherapeutics.com
Primary EmailHow to contact Michael Yellin
Join and see Michael's contact info for free!Current Roles
Employees:
181Revenue:
$15MAbout
Celldex is an innovative biotechnology company focused on the discovery, development and commercialization of targeted immunotherapies. Our core focus includes the use of tumor-specific targets and human monoclonal antibodies as precision delivered therapeutic agents for the treatment of cancer, infectious diseases and immune system disorders through our novel 'active immunization' approach. We have developed our Antigen Presenting Cell Targeting Technology (APC Targeting Technology™) that utilizes proprietary human monoclonal antibodies to directly target specialized types of immune system cells known as antigen presenting cells, or APCs - particularly dendritic cells. We are using this technology approach to build a substantial pipeline of clinical development candidates that will address significant gaps in the treatment of many specific cancers, as well as within our growing activities in infectious disease and auto-immune disordersCelldex Therapeutics Address
53 Frontage RoadHampton, NJ
United States